Atlas Trials

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Clinical trial NCT06177925 · RECRUITING

Trial details

NCT number
NCT06177925
Sponsor
Nanfang Hospital, Southern Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsSmall Cell Lung Carcinoma
Start date
2023-12-10
Primary completion
2026-06-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.